In a letter to the Massachusetts Health Policy Commission, state Attorney General (AG) Maura Healey voiced concerns about the proposed merger between Boston-based Beth Israel Deaconess Medical Center, Burlington, Massachusetts-based Lahey Health and three other healthcare organizations, according to a report from The Boston Globe.
Ms. Healey wrote in her letter that the merger, which would create the second largest health system by revenue in Massachusetts after Boston-based Partners HealthCare, could cause healthcare costs to increase, limit access to care and destabilize independent hospitals, according to the report.
The Commission is responsible for producing an analysis of how the deal will affect costs, quality and access, but it does not have power to block the merger. Ms. Healey does have the authority to do so, however. Her concerns are the first from a state official. The merger was approved by the Massachusetts Department of Public Health in March and the Public Health Council in April. The deal is still pending approval from Ms. Healey and the federal government, according to The Boston Globe.
The AG’s office told The Boston Globe it plans to discuss the deal with executives from Beth Israel Deaconess and Lahey Health. The report suggests Ms. Healey’s office could seek to limit the merger or add other parameters related to pricing or patient mix to help address her concerns.
Full Content: Boston Globe
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
FCC Votes to Restore Net Neutrality Rules
Apr 25, 2024 by
nhoch@pymnts.com
Apple Rejects Spotify’s Updated App Over In-App Pricing Disclosure
Apr 25, 2024 by
CPI
FCC Set to Reinstate Net Neutrality Rules Today
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI